Abstract: Leprosy has been a major burden on humanity over thousands of years. Perhaps no other disease in the history of mankind has been associated with such a strong social stigma as leprosy. Failure in early detection often leads to severe disability in spite of eradication of mycobacteria at a later date. Untreated the disease is progressive and results in permanent damage to the skin, nerves, limbs and eyes. Objectives: To study the pattern of neurological manifestations among adult Sudanese leprosy patients seen in Khartoum Dermatology Hospital in the period from March 2006 to August 2006. Methodology: This is a prospective cross-sectional hospital-based study. Seventy adult Sudanese leprosy patients were studied using simple, direct, standardized questionnaire including history and neurological examination, during the period from March to August 2006.
Perhaps no other disease in the history of mankind has been associated with such a strong social stigma as leprosy. In 1873, Armauer Hansen isolated the bacterium Mycobacterium leprae from the lesions of a Norwegian patient, making leprosy the first disease for which an infectious agent was identified. Failure of early detection often leads to severe disability in spite of eradication of mycobacterium at a later date. The most likely mode of transmission is L through nasal secretions and skin contact. The disease is thought to be of low infectivity. In most populations, over 95% of individuals are naturally immune [2] [3] . In spite of this the disease accounts for approximately 10 million affected people worldwide. Leprosy remained an incurable disease until 1940, when the first breakthrough occurred with the development of dapsone, a drug capable of arresting the disease 4 .Today, it is widely accepted that multi-drug therapy (MDT) renders leprosy curable.
Objective:
To study the pattern of neurological manifestations of leprosy among adult Sudanese patients seen at Khartoum Dermatology Hospital in the period from March 2006 to August 2006.
Methods:
This is a descriptive prospective hospital based cross sectional study. Those below 18 years of age were excluded. All patients gave their consent to participate in the study. A full detailed history and proper systemic and neurological examination was performed by the authors. The physical signs were grouped into general, systemic, dermatological and neurological. According to WHO Skin pigmentation was seen in all (100%) of the patients. Other skin manifestations including macules, plaques, papules, nodules, and ulcers were seen in 78.57%, 44.29%, 14.29%, 12.86% and 5.71% respectively. General clinical findings included cataract which was detected in 2.86%, perforated nasal septum in 2.86%, enlarged nose in 4.29%, saddle nose in 2.86%, lionine face in 1.86%, testicular atrophy in 2.85%, testicular swelling in 1.43% and lower limbs oedema in 1.43%. Almost 61.43% had no sensory impairment over the skin lesions, 12.86% had sensory impairment confined to some skin lesions and 25.71% had sensory impairment over all skin lesions.
The common presenting neurological symptoms were shown in Table2.
Impaired smelling was detected in 12.86%; all had MB disease. Loss of vision in one eye was seen in 4.29%; more than half of them (2.86%) had MB disease. Impaired vision of one eye in 4.29%; all had MB disease. Unilateral LMN facial weakness was detected in 5.71%; half of them had MB disease. 
Discussion:
The study showed that males were affected more than females this is similar to what was mentioned worldwide [5] [6] [7] . It appeared that the age group 18 -27 years is the most common group affected, this is similar to what was reported in the literature. This group being the most active sector of the community highlights the need for early detection and treatment of the disease [8] [9] . The prevalence seemed to decrease with age being less common (5.71%) in the age group >68 years. Geographical distribution showed that 30% of our patients were from the central region, although the disease was found in all other regions. This may be due to easy travel to Khartoum rather than giving a real clue to distribution of the disease in Sudan. Considerable number of patients (28.57%) were farmers raising the possibility of occupational hazards which is not proven yet and needs further scientific verification 5 . The vast majority of our patients (95.71%) had no past history of similar condition; this could be due to the fact that the course of the disease is usually prolonged and silent without remissions and relapses. Almost 90% of our patients had no family history of leprosy, this is similar to a study done in Canada and it differs from what was mentioned in the literature where the presence of family history is increased up to 50% in the endemic countries [7] [8] [9] [10] [11] . We think that family history is very important because proximity to leprosy patients is an important determinant of transmission. Up to 82.86% of our patients had MB form of the disease similar to distribution in some countries (eg. Mexico) but it differs from what has been reported in Africa [12] [13] [14] . The common presenting non-neurological symptoms were found to be skin pigmentation (100%) and nasal discharge (42.86%) similar to what was mentioned in the literature and this is the classical presentation of leprosy particularly MB form 15, 16 . The pattern of skin manifestations among our patients showed that macules (78.57%) and plaques (44.29%) were the most common skin lesions, this is similar to other reports 17, 18 . Considerable number of our patients had no sensory impairment over skin lesions (61.43%), this may be explained by the fact that sensory impairment over skin lesions is an uncommon and a late feature of the MB form of the disease which dominates our patients 19, 20 .
General examination showed variable signs eg. cataract, perforated nasal septum, saddle or enlarged nose, testicular atrophy and lower limbs swelling; this goes with the fact that leprosy is a generalized disease with multisystem involvement [21] [22] [23] . It appeared that numbness (77.14%) and weakness of the limbs (31.43%) were the most common neurological symptoms similar to what was mentioned elsewhere 24, 26 . This is because leprosy affects peripheral nerves leading to sensory disturbance and weakness in addition to destruction of bones 27, 28 . The study showed that impaired smelling was detected in 12.86%, this may be attributed to involvement of nasal mucus membranes by the disease 29, 30 . Lower motor neuron facial weakness was detected in 5.71% but no patient was found to have trigeminal nerve involvement which is similar to what was reported earlier 2, 25, 31 . Impairment or loss of vision was found in smaller numbers, similar to what was mentioned in the literature 32, 33 . Blindness in our study was found to be less than what was mentioned in a study done in Nepal 34 . Examination of upper and lower limbs revealed that wasting, upper limbs weakness and sensory disturbance were found to be the commonest signs. In upper limbs, half of our patients had sensory nerve dysfunction, and approximately half of the patients had motor dysfunction." Gloves" pattern of sensory impairment (30%) was the most common sensory dysfunction, whereas bilateral ulnar distribution weakness (40%) followed by bilateral median distribution weakness (20%) were the most common motor dysfunction. In the lower limbs, significant number of patients (42.86%) exhibited sensory nerve dysfunction, while a minority (4.29%) had motor dysfunction. " Stokes" pattern of sensory impairment (30%) was the most common sensory dysfunction detected in the lower limbs, whereas lateral popliteal weakness (4.29%) was the most common motor dysfunction, this distribution of sensory and motor involvement is more or less similar to what was mentioned by Bogglid et al 7 . However, it seems that our patients were more affected; this can be explained by delayed presentation of our patients and by the fact that most of our patients had MB form of leprosy. The common nerves found to be enlarged was the ulnar nerve, followed by the lateral popliteal and posterior tibial nerves this is slightly different from what was mentioned in the literature 35, 36 . This finding represents the most common presenting sign in leprosy. Almost 21.43% of our patients were found to have reactions at the time of study which is generally in agreement with Andrea K. Bogglid et al findings but differed in that type 2 reaction was found to be more common (14.29%) than type 1 reaction (only 7.14%). 34 This can be explained by the fact that most of our patients had MB form. It appeared that reactions commonly presented with erythematous rashes, nerve pain, arthralgia and fever which is similar to what was mentioned in the literature 37, 38 .
Conclusion:
Numbness and limbs weakness were the most common neurological symptoms in leprosy patients. Peripheral nerve sensory impairment was found in half of the patients with "Gloves and stokes", peripheral sensory neuropathy being the most common sensory disturbance. Motor dysfunction was found in 48.57%. Ulnar and median nerves distribution motor affection was the most common motor dysfunctions. Signs related to cranial nerves involvement were less common. Leprosy reactions were present in one-fifth of the patients. References:
